Dhillon N, Karthikeyan A, Castle A, Dodson P, Högler W, Kirk J, Krone N, Nolan J, Barrett T
Department of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham, UK.
University Hospitals Birmingham Selly Oak Hospital, Birmingham, UK.
Eye (Lond). 2016 Jul;30(7):987-91. doi: 10.1038/eye.2016.60. Epub 2016 Apr 22.
PurposeTo describe the prevalence and natural history of retinopathy in a cohort of children and young people with type 1 diabetes attending a tertiary hospital diabetes clinic.MethodsWe analysed retinopathy screening data from 2008 to 2010 on all eligible children using the 'Twinkle' diabetes database and the regional retinal screening database.ResultsA total of 88% (149/169) of eligible children were screened in 2008, median age 14 years, 52% male. The prevalence of retinopathy was 19.5% (30/149). All children had background retinopathy grade R1. There was significant difference in median (range) duration of diabetes, 7.7 years (0.6-13.7) vs 5 years (0.2-12.5) (P<0.001) and median (range) HbA1C, 9.1% (7.2-14) vs 8.6% (5.6-13.1) (P=0.02), between the groups with and without retinopathy. At 2- years follow-up, 12/30 (40%) had unchanged retinopathy grade R1, 10/30 (33.3%) showed resolution of changes (R0), 1/30 progressed to maculopathy, and 7/30 had no follow-up data. Median (range) HbA1C in 2008 and 2010 for the groups with stable vs resolved changes was similar, 9.1% (7.2-14.0) and 9.2% (7-14.0) vs 9.5% (7.8-14.0) and 9.2% (8.7-14.0). Of the 119 without retinopathy in 2008, 27 (22.5%) had developed retinopathy within 2 years, including 1 with pre-proliferative retinopathy and 1 with maculopathy. There was no significant difference in HbA1c between those who progressed to retinopathy (8.7% (7.1-13.1)) (8.7% (7.1-13.1)), and those who did not (8.6% (6.3-12.2)).ConclusionsPrevalence of background retinopathy in our cohort was comparable to the previously published reports, with higher HbA1c and longer duration of diabetes being significant risk factors. On short-term follow-up, Grade 1 retinopathy is likely to resolve in a third of patients and remain unchanged in just over a third.
描述在一家三级医院糖尿病门诊就诊的1型糖尿病儿童和青少年队列中视网膜病变的患病率及自然病程。
我们使用“Twinkle”糖尿病数据库和区域视网膜筛查数据库分析了2008年至2010年所有符合条件儿童的视网膜病变筛查数据。
2008年共有88%(149/169)符合条件的儿童接受了筛查,中位年龄14岁,52%为男性。视网膜病变的患病率为19.5%(30/149)。所有儿童均为背景性视网膜病变R1级。有视网膜病变组与无视网膜病变组在糖尿病病程中位数(范围)上存在显著差异,分别为7.7年(0.6 - 13.7)和5年(0.2 - 12.5)(P<0.001),HbA1C中位数(范围)也有显著差异,分别为9.1%(7.2 - 14)和8.6%(5.6 - 13.1)(P = 0.02)。在2年随访中,30例中有12例(40%)视网膜病变等级R1未变,10例(33.3%)病变消失(R0),1例进展为黄斑病变,7例无随访数据。2008年和2010年病变稳定组与病变消失组的HbA1C中位数(范围)相似,分别为9.1%(7.2 - 14.0)和9.2%(7 - 14.0)以及9.5%(7.8 - 14.0)和9.2%(8.7 - 14.0)。2008年无视网膜病变的119例中,27例(22.5%)在2年内出现了视网膜病变,其中1例为增殖前期视网膜病变,1例为黄斑病变。进展为视网膜病变者与未进展者的HbA1c无显著差异(分别为8.7%(7.1 - 13.1)和8.6%(6.3 - 12.2))。
我们队列中背景性视网膜病变的患病率与先前发表的报告相当,较高的HbA1c和较长的糖尿病病程是显著的危险因素。在短期随访中,三分之一的患者1级视网膜病变可能消失,略多于三分之一的患者病变保持不变。